Piperacillin
Mostrando 13-24 de 521 artigos, teses e dissertações.
-
13. Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract
Since antimicrobial resistance among uropathogens against current first line agents has affected the management of severe urinary tract infection, we determined the likelihood that antibiotic regimens achieve bactericidal pharmacodynamic exposures using Monte Carlo simulation for five antimicrobials (ciprofloxacin, ceftriaxone, piperacillin/tazobactam, ertap
Braz J Infect Dis. Publicado em: 2014-09
-
14. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
To review the epidemiology of nosocomial extended spectrum β-lactamase-producing Enterobacteriaceae in Latin America, a systematic search of the biomedical literature (PubMed) was performed for articles published since 2005. Rates of nosocomial infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in Latin America have increased s
Braz J Infect Dis. Publicado em: 2014-08
-
15. Prevalence and antibiotic susceptibility of Bacteroides fragilis group isolated from stool samples in North Lebanon
Fifty one strains of the Bacteroides fragilis group were isolated from 45 fecal samples. Classical phenotypic identification showed that 16 isolates were B. thetaiotaomicron, 12 B. uniformis, 9 B. eggerthii,7 B. vulgatus,3 B. caccae,2 Parabacteroides distasonis with 1 identified B. ovatus and 1 B. fragilis. The 51 strains were tested for susceptibility again
Braz. J. Microbiol.. Publicado em: 2013-09
-
16. Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until c
Braz J Infect Dis. Publicado em: 2013-08
-
17. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
Introduction Pseudomonas aeruginosa isolates related to nosocomial infections are often resistant to multiple antibacterial agents. In this study, antimicrobial combinations were evaluated to detect in vitro synergy against clinical isolates of P. aeruginosa. Methods Four clinical P. aeruginosa isolates were selected at random among other isolates from in
Rev. Soc. Bras. Med. Trop.. Publicado em: 2013-06
-
18. Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units
OBJECTIVE: This observational study described the characterization of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units. The demonstration of isolated microorganism resistance to antibiotics and a time-trend analysis of infection comparing a 48-month period were also other objectives. METHOD: Semi-
Brazilian Journal of Infectious Diseases. Publicado em: 2012-02
-
19. Wound infections secondary to snakebite in central Taiwan
There are very few microbiological data on wound infections following snakebites. The objective of this study was to investigate the treatment of secondary infection following snakebites in central Taiwan. Microbiological data and antibiotic sensitivity of wound cultures were retrospectively analyzed from December 2005 to October 2007 in a medical center in
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 2012
-
20. Shewanella infection of snake bites: a twelve-year retrospective study
OBJECTIVE: Infections of snake bite wounds by Shewanella are rarely discussed in the medical literature. This study aims to characterize the presentation and management of Shewanella infections in snake bite wounds. METHOD: We retrospectively investigated the microbiology, clinical features, and outcomes of patients with Shewanella infected snake bite wounds
Clinics. Publicado em: 2012
-
21. Distribution, detection of enterotoxigenic strains and antimicrobial drug susceptibility patterns of Bacteroides fragilis group in diarrheic and non-diarrheic feces from Brazilian infants
Despite the importance of gastrointestinal diseases and their global distribution, affecting millions of individuals around the world, the role and antimicrobial susceptibility patterns of anaerobic bacteria such as those in the Bacteroides fragilis group (BFG) are still unclear in young children. This study investigated the occurrence and distribution of sp
Brazilian Journal of Microbiology. Publicado em: 2010-10
-
22. Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
Piperacillin-tazobactam is a broad spectrum antimicrobial agent that can cause false-positive results in the commercial Platelia Aspergillus EIA test. So far, no study has been performed in Latin America to evaluate the clinical implication of this finding. Here we studied the potential for galactomannan detection in piperacillin-tazobactam batches commercia
Brazilian Journal of Infectious Diseases. Publicado em: 2009-10
-
23. Aplicações e limitações do método de detecção do antígeno galactomanana para o diagnóstico de aspergilose / Applications and limitations of a galactomannan detection method in the diagnostic of aspergillosis
O Platelia® Aspergillus EIA é um teste de ELISA sanduíche para diagnóstico precoce de aspergilose em pacientes neutropênicos que se baseia na detecção de um antígeno (galactomanana) da parede celular de Aspergillus spp. O trabalho objetivou avaliar a eficácia deste teste em outros hospedeiros suscetíveis à aspergilose e ainda, avaliar a interferê
Publicado em: 2009
-
24. Rates of antimicrobial resistance in latin america (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics
As a part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), Gram-positive and Gram-negative bacterial isolates were collected from 33 centers in Latin America (centers in Argentina, Brazil, Chile, Colombia, Guatemala, Honduras, Jamaica, Mexico, Panama, Puerto Rico, and Venezuela) from January 2004 to September 2007. Argentina and Mexico were t
Brazilian Journal of Infectious Diseases. Publicado em: 2008-10